Loading...
Loading...
Analysts at Wedbush initiated coverage on shares of Novavax
NVAX with a Outperform rating.
The target price for Novavax is set to $10.
Novavax shares have jumped 43.59% over the past 52 weeks, while the S&P 500 index has gained 17.63% in the same period.
Novavax's shares rose 0.67% to $4.51 in after-hours trading.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in